Home › Hemophilia › Michigan
Hemophilia clinical trials in Michigan
7 studies for Hemophilia are looking for participants at sites in Michigan.
Cities in Michigan
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- University of Michigan - 1500 E Medical Center Dr, Ann Arbor
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 3, 2026 · NCT07416604A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- University of Michigan Health System - Ann Arbor- Site Number : 8400003, Ann Arbor
RecruitingPhase 3
Ages 1 to 11 · Men · Updated Oct 27, 2026 · NCT07285460ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Central Michigan Children's Hospital of Michigan, Detroit
- Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Children's Hospital of Michigan, Detroit
RecruitingObservational study
Ages 6 to 19 · All sexes · Updated Jul 2, 2026 · NCT05022459A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- University of Michigan Hospitals - Michigan Medicine, Ann Arbor
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 60 · All sexes · Updated Jul 2, 2026 · NCT06349473Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- University of Michigan Medical School, Ann Arbor
- Central Michigan University: Children's Hospital of Michigan, Mount Pleasant
RecruitingPhase 1
Ages 0 to 90 · All sexes · Updated Apr 3, 2026 · NCT05500807SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Children's Hospital of Michigan, Detroit
- Henry Ford Health System, Detroit
- MSU Center for Bleeding and Clotting Disorders, Lansing
RecruitingPhase 4
Ages 12 to 100 · All sexes · Updated Jan 12, 2026 · NCT04647227From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.